Mark Ainsworth

ORCID: 0000-0002-4899-1048
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Numerical Methods in Computational Mathematics
  • Inflammatory Bowel Disease
  • Numerical methods in engineering
  • Microscopic Colitis
  • Electromagnetic Simulation and Numerical Methods
  • Advanced Mathematical Modeling in Engineering
  • Immunodeficiency and Autoimmune Disorders
  • Lattice Boltzmann Simulation Studies
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Electromagnetic Scattering and Analysis
  • Advanced Numerical Analysis Techniques
  • Model Reduction and Neural Networks
  • SARS-CoV-2 and COVID-19 Research
  • Differential Equations and Numerical Methods
  • Biosimilars and Bioanalytical Methods
  • Computational Fluid Dynamics and Aerodynamics
  • SARS-CoV-2 detection and testing
  • Innovations in Medical Education
  • Liver Disease Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Eosinophilic Esophagitis
  • Pharmaceutical studies and practices
  • Distributed and Parallel Computing Systems
  • Intensive Care Unit Cognitive Disorders

Odense University Hospital
1997-2025

John Brown University
2015-2024

Oxford University Hospitals NHS Trust
2015-2024

University of Oxford
2017-2024

University of Southern Denmark
2000-2024

Brown University
2015-2024

Imperial College London
2022-2024

University of Liverpool
2022-2023

Newcastle upon Tyne Hospitals NHS Foundation Trust
2023

Manchester Academic Health Science Centre
2023

10.1016/s0045-7825(96)01107-3 article EN Computer Methods in Applied Mechanics and Engineering 1997-03-01

The impact of COVID-19 on physical and mental health employment after hospitalisation with acute disease is not well understood. aim this study was to determine the effects COVID-19-related employment, identify factors associated recovery, describe recovery phenotypes. Post-hospitalisation (PHOSP-COVID) a multicentre, long-term follow-up adults (aged ≥18 years) discharged from hospital in UK clinical diagnosis COVID-19, involving an assessment between 2 7 months discharge, including detailed...

10.1016/s2213-2600(21)00383-0 article EN cc-by The Lancet Respiratory Medicine 2021-10-09
Eugenia Abaleke Mustafa Abbas Sadia Abbasi Alfie Abbott Ashraf Omar Abdelaziz and 95 more Sherif Abdelbadiee Mohamed S. Attia Basir Abdul Althaf Abdul Rasheed Rezan A. Kadir Abdulfatahi Abdulmumeen Niyaz Abdulshukkoor Kula Abdusamad Yazeed Abed El Khaleq Mai Abedalla Abeer UA Abeer Ul Amna Adebanke Aboaba Hani Abo-Leyah Ahmed Abou-Haggar Mahmoud Abouibrahim Miriam Abraham Tizzy Abraham Abraheem Abraheem Judith Abrams Hyacinth-John Abu Ahmad Abu-Arafeh Syed M Abubacker Akata Abung Yaa Aceampong Devikumar Acharya Janet Acheson Andrés Acosta Catherine Acton Jacqueline Adabie-Ankrah Fiona Adam Matthew Adam Huzaifa Adamali Carol Adams Kate Adams Richard Adams Tim Adams Malgorzata Adamus Kirsty Adcock Aderonke Adebiyi Ken Adegoke Vicki Adell Aldrin Adeni Sherna Adenwalla Oluwasegun A Adesemoye Emmanuel O Adewunmi Joyce Adeyemi Elizabeth Adeyeye Gabrielle Adkins Adnan Adnan John Aeron‐Thomas Lynn Afari Debbie Affleck Carmel Afnan Deborah Afolabi Muhammad Abdur Rahman Afridi Rachel Agbeko Chris Agbo Sunil Aggarwal Arameh Aghababaie Judith Agwada-Akeru Kwame A Agyapong Shafana Ahamed Sadiq Mohamed H Ahammed Nazeer Jonathan Ah-Chuen Mahin Ahmad Ashar Ahmed Bilal Ahmed Forizuddin Ahmed Iram Ahmed Irshad Ahmed Liban Ahmed Maria C Ahmed Muhammad S. Ahmed Naseer Ahmed Nausheen Ahmed Osama Ahmed Rajia A Ahmed Rizwan Ahmed Saif Ahmed Sammiya Ahmed Sara Ahmed Syed Haris Ahmed Roa Ahmed Ali Sana Ahmer Dhiraj Ail Adam Ainsley Mark Ainsworth Myriam Aissa Lucy Aitchson Lindianne Aitken Bini Ajay Abdulakeem Ajibode Ayesha Ajmi Muhammad Nadeem Akhtar Nasim Akhtar

10.1016/s0140-6736(21)00149-5 article EN cc-by The Lancet 2021-02-01

Although the reasons for secondary loss of response to infliximab (IFX) maintenance therapy in Crohn's disease vary, dose intensification is usually recommended. This study investigated cost-effectiveness interventions defined by an algorithm designed identify specific therapeutic failure.Randomised, controlled, single-blind, multicentre study. 69 patients with IFX failure were randomised (5 mg/kg every 4 weeks) (n=36) or based on serum and antibody levels using proposed (n=33). Predefined...

10.1136/gutjnl-2013-305279 article EN Gut 2013-07-22
Mark Ainsworth Monique Andersson Kathryn Auckland J. Kenneth Baillie Eleanor Barnes and 95 more Sally Beer Amy Beveridge Sagida Bibi Luke Blackwell Martyna Borak Abbie Bown Tim Brooks N. Burgess-Brown Susana Camara Matthew Catton Kevin Chau Thomas Christott Elizabeth Clutterbuck Jesse A. Coker Richard J. Cornall Stuart Cox David Crawford-Jones Derrick W. Crook Silvia D’Arcangelo Wanwisa Dejnirattsai Julie Dequaire Stavros Dimitriadis Kate E. Dingle George Doherty Christina Dold Tao Dong Susanna Dunachie Daniel Ebner Marc Emmenegger Alexis Espinosa David W. Eyre Rory Fairhead Shayan Fassih Conor Feehily Sally Felle Alejandra Fernandez‐Cid Maria Fernandez Mendoza Thomas Foord Thomas Fordwoh Deborah McKee John Frater Verónica Sánchez Nick Gent Dominique Georgiou Christopher J. Groves Bassam Hallis Peter Hammond Stephanie B. Hatch Heli Harvala Jennifer Hill Sarah Hoosdally Bryn Horsington Alison Howarth Tim James Katie Jeffery Elizabeth Jones Anita Justice Fredrik Karpe James Kavanagh David Kim Richard Kirton Paul Klenerman Julian C. Knight Leonidas Koukouflis Andrew Kwok U Leuschner Robert H. Levin Aline Linder Teresa Lockett Sheila Lumley Spyridoula Marinou Brian D. Marsden José Luis Martínez Lucas Martins Ferreira Lara Hannan Mason Philippa C. Matthews Alexander J. Mentzer Alexander Mobbs Juthathip Mongkolsapaya Jordan Morrow Shubhashish Mukhopadhyay Matthew Neville Sarah Oakley Marta Oliveira Ashley Otter Kevin Paddon Jordan Pascoe Yanchun Peng Elena Perez Prem Perumal Tim Peto Hayleah Pickford Rutger J. Ploeg Andrew J. Pollard Anastasia Richardson

<h2>Summary</h2><h3>Background</h3> Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic in 2020. Testing is crucial for mitigating public health and economic effects. Serology considered key to population-level surveillance potentially individual-level risk assessment. However, immunoassay performance not been compared on large, identical sample sets. We aimed investigate the of four high-throughput commercial SARS-CoV-2 antibody immunoassays novel...

10.1016/s1473-3099(20)30634-4 article EN cc-by The Lancet Infectious Diseases 2020-09-24

No effective pharmacological or non-pharmacological interventions exist for patients with long COVID. We aimed to describe recovery 1 year after hospital discharge COVID-19, identify factors associated patient-perceived recovery, and potential therapeutic targets by describing the underlying inflammatory profiles of previously described clusters at 5 months discharge.

10.1016/s2213-2600(22)00127-8 article EN cc-by The Lancet Respiratory Medicine 2022-04-23
David Ahern Zhichao Ai Mark Ainsworth Chris Allan Alice Allcock and 95 more Brian Angus M. Azim Ansari Carolina V. Arancibia-Cárcamo Dominik Aschenbrenner Moustafa Attar J. Kenneth Baillie Eleanor Barnes Rachael Bashford-Rogers Archana Bashyal Sally Beer G. Berridge Amy Beveridge Sagida Bibi Tihana Bicanic Luke Blackwell Paul Bowness Andrew Brent Andrew Brown John Broxholme David Buck Katie L. Burnham Helen M. Byrne Susana Camara Ivan Candido-Ferreira Philip D. Charles Wentao Chen Yi‐Ling Chen Amanda Y. Chong Elizabeth Clutterbuck Mark Coles Christopher P. Conlon Richard J. Cornall Adam P. Cribbs Fabiola Curion Emma E. Davenport Neil Davidson Simon Davis Calliope A. Dendrou Julie Dequaire Lea Dib James Docker Christina Dold Tao Dong Damien J. Downes Hal Drakesmith Susanna Dunachie David A. Duncan Chris Eijsbouts Robert Esnouf Alexis Espinosa Rachel Etherington Benjamin P. Fairfax Rory Fairhead Hai Fang Shayan Fassih Sally Felle Maria Fernandez Mendoza Ricardo Melo Ferreira Román Fischer Thomas Foord Aden Forrow John Frater Anastasia Fries Verónica Sánchez Lucy C. Garner Clementine Geeves Dominique Georgiou Leila Godfrey Tanya Golubchik Maria Gomez Vazquez Angie Green Hong Harper Heather A. Harrington Raphael Heilig Svenja Hester Jennifer Hill Charles Hinds Clare Hird Ling‐Pei Ho Renee S. Hoekzema Benjamin Hollis Jim R. Hughes Paula Hutton Matthew A. Jackson-Wood Ashwin Jainarayanan Anna James-Bott Kathrin Jansen Katie Jeffery Elizabeth Jones Luke Jostins Georgina Kerr David Kim Paul Klenerman Julian C. Knight Vinod Kumar

Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete description specific immune biomarkers. We present here a comprehensive multi-omic blood atlas for patients with varying severity in an integrated comparison influenza sepsis versus healthy volunteers. identify signatures correlates host response. Hallmarks disease involved cells, their inflammatory mediators networks, including progenitor cells myeloid lymphocyte subsets, features the repertoire,...

10.1016/j.cell.2022.01.012 article EN cc-by Cell 2022-01-21

<ns3:p><ns3:bold>Background:</ns3:bold> The COVID-19 pandemic caused &gt;1 million infections during January-March 2020. There is an urgent need for reliable antibody detection approaches to support diagnosis, vaccine development, safe release of individuals from quarantine, and population lock-down exit strategies. We set out evaluate the performance ELISA lateral flow immunoassay (LFIA) devices.</ns3:p><ns3:p> <ns3:bold>Methods:</ns3:bold> tested plasma COVID (severe acute respiratory...

10.12688/wellcomeopenres.15927.1 preprint EN cc-by Wellcome Open Research 2020-06-11

10.1016/j.eclinm.2021.100924 article EN cc-by-nc-nd EClinicalMedicine 2021-05-30

ABSTRACT Background The COVID-19 pandemic caused &gt;1 million infections during January-March 2020. There is an urgent need for reliable antibody detection approaches to support diagnosis, vaccine development, safe release of individuals from quarantine, and population lock-down exit strategies. We set out evaluate the performance ELISA lateral flow immunoassay (LFIA) devices. Methods tested plasma COVID (SARS-CoV-2) IgM IgG antibodies by using nine different LFIA used a panel samples who...

10.1101/2020.04.15.20066407 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2020-04-20
Felicity Liew Claudia Efstathiou Sara Fontanella Matthew Richardson Ruth Saunders and 95 more Dawid Swieboda Jasmin Sidhu Stephanie Ascough Shona C. Moore Noura Mohamed J Nunag Clara King Olivia C. Leavy Omer Elneima Hamish McAuley Aarti Shikotra Amisha Singapuri Marco Sereno Victoria Harris Linzy Houchen-Wolloff Neil Greening Nazir Lone Matthew Thorpe A. A. Roger Thompson Sarah Rowland–Jones Annemarie B Docherty James D. Chalmers Ling‐Pei Ho Alex Horsley Betty Raman Krisnah Poinasamy Michael Marks Onn Min Kon Luke Howard Dan Wootton Jennifer K Quint Thushan I. de Silva Antonia Ho Christopher Chiu Ewen M. Harrison William Greenhalf J. Kenneth Baillie Malcolm G. Semple Lance Turtle Rachael A. Evans Louise V. Wain Christopher E. Brightling Ryan S. Thwaites Peter Openshaw Kathryn M. Abel Huzaifa Adamali Davies Adeloye Oluwaseun Adeyemi Rita Adrego L A Aguilar Jimenez Shanaz Ahmad Nafees Haider Rubina Ahmed Nyarko Ahwireng Mark Ainsworth Asma Alamoudi Mariam Ali M Aljaroof Louise Allan Richard J. Allen L. Allerton Lynne Allsop Ann Marie Allt Paula Almeida Bashar Al‐Sheklly Daniel M. Altmann Maria Alvarez Corral Shannon Amoils David Anderson Charalambos Antoniades Gill Arbane Ava Maria Arias Chérie Armour Lisa Armstrong Natalie Armstrong David Arnold H Arnold Abdul Ashish Andrew Ashworth Milton Ashworth Shahab Aslani H Assefa-Kebede Paul Atkin Catherine Atkin Raminder Aul Hnin Aung Liam Austin Cristina Avram Nikos Avramidis A Ayoub Marta Babores Rhiannon R Baggott J. Bagshaw David Baguley Elisabeth Bailey

One in ten severe acute respiratory syndrome coronavirus 2 infections result prolonged symptoms termed long disease (COVID), yet phenotypes and mechanisms are poorly understood

10.1038/s41590-024-01778-0 article EN cc-by Nature Immunology 2024-04-01

The dispersive properties of high order finite element schemes are analyzed in the setting Helmholtz equation, and an explicit form discrete dispersion relation is obtained for elements arbitrary order. It shown that numerical displays three different types behavior, depending on size method relative to mesh-size wave number. Quantitative estimates behavior rates decay error differing regimes. All fully be sharp. Limits obtained, where transitions between regimes occur, used provide...

10.1137/s0036142903423460 article EN SIAM Journal on Numerical Analysis 2004-01-01

Introduction. Reasons for infliximab failure in Crohn's disease and ulcerative colitis are debated. Serum levels of anti-infliximab antibodies have been associated with loss response. We aimed at determining cut-off antibody concentrations clinical response to maintenance therapy. Methods. Patients inflammatory bowel (n = 106) were retrospectively classified as having maintained or Trough measured by fluid-phase radioimmunoassays. Results. Infliximab significantly lower, higher, patients...

10.3109/00365521.2010.536254 article EN Scandinavian Journal of Gastroenterology 2010-11-18

Abstract An a‐posteriori error estimator for finite element analysis proposed by Zienkiewicz and Zhu is analysed shown to be effective convergent. In addition we analyse wider classes of estimators which the Zienkiewicz–Zhu a special case. It that some these will asymptotically exact . Numerical evidence presented supporting analysis.

10.1002/nme.1620280912 article EN International Journal for Numerical Methods in Engineering 1989-09-01

We derive a fractional Cahn--Hilliard equation (FCHE) by considering gradient flow in the negative order Sobolev space $H^{-\alpha}$, $\alpha\in [0,1]$, where choice $\alpha=1$ corresponds to classical while $\alpha=0$ recovers Allen--Cahn equation. The existence of unique solution is established and it shown that preserves mass for all positive values $\alpha$ indeed reduces free energy. then turn delicate question $L_\infty$ boundedness establish an bound FCHE case nonlinearity quartic...

10.1137/16m1075302 article EN SIAM Journal on Numerical Analysis 2017-01-01

To investigate if the combined assessment of anti-infliximab antibodies (Ab) and degree TNF-alpha binding capacity (TNF-alpha-BC) afforded by infliximab may predict response to treatment in patients with Crohn's disease (CD).Three groups CD patients, total 33 treated were retrospectively selected: (a) a maintained throughout treatment; (b) good initial response, but subsequent loss response; (c) inadequate first two or three doses. Blood samples analyzed for TNF-alpha-BC Ab using fluid-phase...

10.1111/j.1572-0241.2007.01638.x article EN The American Journal of Gastroenterology 2007-11-21

The Cancer Genomics Hub (CGHub) is the online repository of sequencing programs National Institute (NCI), including Atlas (TCGA), Cell Line Encyclopedia (CCLE) and Therapeutically Applicable Research to Generate Effective Treatments (TARGET) projects, with data from 25 different types cancer. CGHub currently contains >1.4 PB data, has grown at an average rate 50 TB a month serves >100 per week. architecture designed support bulk searching downloading through Web-accessible application...

10.1093/database/bau093 article EN cc-by Database 2014-09-29

Aliment Pharmacol Ther 2011; 34: 51–58 Summary Background Infliximab (IFX) elicits acute severe infusion reactions in about 5% of patients with inflammatory bowel disease (IBD). Aim To investigate the role anti-IFX antibodies (Ab) and other risk factors. Methods The study included all IBD treated IFX at a Danish university hospital until 2010 either continuously (IFX every 4–12 weeks) or episodically (reinitiation after >12 weeks). Anti-IFX Ab were measured using radioimmunoassay. Results...

10.1111/j.1365-2036.2011.04682.x article EN Alimentary Pharmacology & Therapeutics 2011-05-03
Coming Soon ...